Farallon Capital
Farallon Capital Management · SEC CIK 909661
Event-driven value with a risk-arb spine.
Q1 2026
Latest 13F
$17.54B
Filed US book
172
Positions
Largest holdings, as filed
Top 15 of 172 positions. Weights are against the whole filed book. 13F filings cover US-listed holdings only.
| Company | Ticker | Value | Weight |
|---|---|---|---|
| STATE STR SPDR S&P 500 ETF T(Put) | $1.50B | 8.5% | |
| REVOLUTION MEDICINES INC | RVMD | $1.32B | 7.5% |
| AMAZON COM INC | AMZN | $878.56M | 5.0% |
| MICROSOFT CORP | MSFT | $867.97M | 5.0% |
| AON PLC | $811.03M | 4.6% | |
| BRIDGEBIO PHARMA INC | BBIO | $695.48M | 4.0% |
| INVESCO EXCHANGE TRADED FD T(Put) | $690.91M | 3.9% | |
| PROTAGONIST THERAPEUTICS INC | PTGX | $669.17M | 3.8% |
| NATERA INC | NTRA | $641.44M | 3.7% |
| EXELIXIS INC | EXEL | $562.33M | 3.2% |
| BROADCOM INC | AVGO | $550.77M | 3.1% |
| UNITEDHEALTH GROUP INC | UNH | $492.94M | 2.8% |
| SYNOPSYS INC | SNPS | $481.05M | 2.7% |
| BOSTON SCIENTIFIC CORP | BSX | $468.79M | 2.7% |
| THERMO FISHER SCIENTIFIC INC | TMO | $433.28M | 2.5% |
Inside the app: the full book for Farallon Capital Management, quarter on quarter buys and sells, consensus across 100+ funds and copy-to-watchlist.
Source: SEC EDGAR 13F filings. Values are as filed and cover US-listed positions only. Educational information, not financial advice.